1.0KFF Health Newshttps://kffhealthnews.orgbrilabuskeshttps://kffhealthnews.org/news/author/brilabuskes/rich600338<blockquote class="wp-embedded-content" data-secret="u10hhrI7Vu"><a href="https://kffhealthnews.org/morning-breakout/renewed-scrutiny-of-340b-program-seems-like-win-for-pharma-but-drugmakers-shouldnt-celebrate-yet/">Renewed Scrutiny Of 340B Program Seems Like Win For Pharma, But Drugmakers Shouldn’t Celebrate Yet</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://kffhealthnews.org/morning-breakout/renewed-scrutiny-of-340b-program-seems-like-win-for-pharma-but-drugmakers-shouldnt-celebrate-yet/embed/#?secret=u10hhrI7Vu" width="600" height="338" title="“Renewed Scrutiny Of 340B Program Seems Like Win For Pharma, But Drugmakers Shouldn’t Celebrate Yet” — KFF Health News" data-secret="u10hhrI7Vu" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> Both Republicans and Democrats in Congress show interest in increasing oversight to the drug discount program that the pharmaceutical industry wants reined in. But lawmakers' attention isn't solely directed at the role of hospitals. Meanwhile, House Ways and Means Committee Chairman Kevin Brady (R-Texas) plans a hearing about President Donald Trump's plans to curb high drug prices, and the industry's lobbying group has some "serious concerns" with the president's blueprint.